Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-07 Tax Withholding |
2025-03-11 5:48 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | TOTH A ERNEST JR Chief Financial Officer |
18,929 | $2.65 | 399,366 (Direct) |
View |
| 2025-03-07 Option Award |
2025-03-11 5:48 pm |
N/A 2035-03-07 |
Aquestive Therapeutics Inc. | AQST | TOTH A ERNEST JR Chief Financial Officer |
170,000 | $0 | 399,366 (Direct) |
View |
| 2024-03-09 Tax Withholding |
2024-03-12 1:47 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | TOTH A ERNEST JR SVP, Chief Financial Officer |
11,705 | $4.88 | 248,295 (Direct) |
View |
| 2024-03-07 Option Award |
2024-03-11 10:36 am |
N/A 2034-03-07 |
Aquestive Therapeutics Inc. | AQST | TOTH A ERNEST JR SVP, Chief Financial Officer |
180,000 | $0 | 320,000 (Direct) |
View |
| 2023-08-09 Option Award |
2023-08-09 4:30 pm |
N/A 2026-05-05 |
Aquestive Therapeutics Inc. | AQST | TOTH A ERNEST JR SVP, Chief Financial Officer |
70,000 | $0 | 70,000 (Direct) |
View |
| 2023-05-05 Option Award |
2023-05-05 4:00 pm |
N/A 2026-05-05 |
Aquestive Therapeutics Inc. | AQST | TOTH A ERNEST JR SVP, Chief Financial Officer |
70,000 | $0 | 70,000 (Direct) |
View |
| 2023-03-09 Option Award |
2023-03-09 3:05 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | TOTH A ERNEST JR SVP, Chief Financial Officer |
140,000 | $0 | 140,000 (Direct) |
View |
| 2022-11-04 Option Award |
2022-11-08 10:21 am |
N/A 2032-11-04 |
Aquestive Therapeutics Inc. | AQST | TOTH A ERNEST JR SVP, Chief Financial Officer |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-03-10 Option Award |
2022-03-14 11:26 am |
N/A 2032-03-10 |
Aquestive Therapeutics Inc. | AQST | TOTH A ERNEST JR Interim CFO |
70,000 | $0 | 70,000 (Direct) |
View |
| 2021-06-15 Option Award |
2021-06-17 6:51 pm |
N/A 2031-06-15 |
Aquestive Therapeutics Inc. | AQST | TOTH A ERNEST JR SVP, Chief Financial Officer |
120,000 | $0 | 120,000 (Direct) |
View |
| 2021-03-11 Option Award |
2021-03-15 5:10 pm |
N/A 2031-03-11 |
Aquestive Therapeutics Inc. | AQST | TOTH A ERNEST JR Interim CFO |
2,500 | $0 | 2,500 (Direct) |
View |